InsidersTradesSigma
Follow the Physiomics plc share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are quoted on the UK market, under the oversight of RNS (LSE). The latest transaction was disclosed on 14 July 2026 (Purchase). Among the most active insiders: Ian Bagnall. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Physiomics plc is a biotechnology company focused on developing modeling solutions for cancer treatment. It utilizes advanced technologies to optimize therapies and enhance clinical outcomes.